Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

Introduction: Thoracic radiotherapy (TRT) is increasingly used in patients receiving osimertinib for advanced NSCLC, and the risk of pneumonitis is not established. We investigated the risk of pneumonitis and potential risk factors in this population. Methods: We performed a multi-institutional retr...

Full description

Bibliographic Details
Published in:JTO Clinical and Research Reports
Main Authors: Leou Ismael Banla, MD, PhD, Alice Tzeng, MD, PhD, John P. Baillieul, Melin J. Kandekhar, MD, PhD, Kelly J. Fitzgerald, MD, PhD, Jaclyn LoPiccolo, MD, PhD, Holly A. Poitras, Daniel E. Soto, MD, Julia K. Rotow, MD, Lisa Singer, MD, PhD, Henning Willers, MD, David E. Kozono, MD, PhD, Pasi A. Janne, MD, PhD, Raymond H. Mak, MD, Zofia Piotrowska, MD, Florence K. Keane, MD, Benjamin H. Kann, MD
Format: Article
Language:English
Published: Elsevier 2023-10-01
Subjects:
Pneumonitis
Osimertinib
Radiation
Lung cancer
Tyrosine kinase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364323001029

Internet

http://www.sciencedirect.com/science/article/pii/S2666364323001029

Similar Items